180 related articles for article (PubMed ID: 36706663)
1. Sodium dehydroacetate-induced disorder of coagulation function in broiler chickens and the protective effect afforded by vitamin K.
Xu J; Hao F; Wang C; Zhao Z; Zhang M; Chen X; Zhang Y
Poult Sci; 2023 Mar; 102(3):102482. PubMed ID: 36706663
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of VKORC1 and VKORC1L1 signaling in the effects of sodium dehydroacetate on coagulation factors in rat hepatocytes.
Zhou Z; Chen B; Zhang M; Chen X; Zhang Y
Toxicol In Vitro; 2023 Mar; 87():105518. PubMed ID: 36403723
[TBL] [Abstract][Full Text] [Related]
3. Sodium dehydroacetate induces coagulation dysfunction by inhibiting liver vitamin K epoxide reductase complex subunit 1 in Wistar rats.
Chen X; Wei Q; Lu Q; Zhao Z; Yu Z; Zhang Y
Res Vet Sci; 2019 Jun; 124():399-405. PubMed ID: 31078787
[TBL] [Abstract][Full Text] [Related]
4. The mechanism of blood coagulation induced by sodium dehydroacetate via the regulation of the mTOR/ERK pathway in rats.
Zhang M; Zhang Q; Zhao W; Chen X; Zhang Y
Toxicol Lett; 2024 Feb; 392():1-11. PubMed ID: 38103582
[TBL] [Abstract][Full Text] [Related]
5. Anticoagulant effect of sodium dehydroacetate (DHA-S) in rats.
Sakaguchi Y; Suga S; Oshida K; Miyamoto-Kuramitsu K; Ueda K; Miyamoto Y
J Appl Toxicol; 2008 May; 28(4):524-9. PubMed ID: 17941040
[TBL] [Abstract][Full Text] [Related]
6. Sex Metabolic Differences and Effects on Blood Coagulation Among Rats Exposed to Sodium Dehydroacetate.
Chen X; Hao F; Zhang M; Xiao J; Zhao W; Zhao Z; Zhang Y
Front Pharmacol; 2021; 12():727084. PubMed ID: 34594221
[TBL] [Abstract][Full Text] [Related]
7. VKORC1L1, An Enzyme Mediating the Effect of Vitamin K in Liver and Extrahepatic Tissues.
Lacombe J; Ferron M
Nutrients; 2018 Jul; 10(8):. PubMed ID: 30050002
[TBL] [Abstract][Full Text] [Related]
8. Serum pharmacokinetics and coagulation aberration induced by sodium dehydroacetate in male and female Wistar rats.
Zhang Y; Ying D; Liu H; Yu Z; Han L; Xie J; Xie Y
Sci Rep; 2017 Apr; 7():46210. PubMed ID: 28387309
[TBL] [Abstract][Full Text] [Related]
9. VKORC1L1, an enzyme rescuing the vitamin K 2,3-epoxide reductase activity in some extrahepatic tissues during anticoagulation therapy.
Hammed A; Matagrin B; Spohn G; Prouillac C; Benoit E; Lattard V
J Biol Chem; 2013 Oct; 288(40):28733-42. PubMed ID: 23928358
[TBL] [Abstract][Full Text] [Related]
10. Two enzymes catalyze vitamin K 2,3-epoxide reductase activity in mouse: VKORC1 is highly expressed in exocrine tissues while VKORC1L1 is highly expressed in brain.
Caspers M; Czogalla KJ; Liphardt K; Müller J; Westhofen P; Watzka M; Oldenburg J
Thromb Res; 2015 May; 135(5):977-83. PubMed ID: 25747820
[TBL] [Abstract][Full Text] [Related]
11. New Insights on Vitamin K Metabolism in Senegalese sole (
Beato S; Marques C; Laizé V; Gavaia PJ; Fernández I
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429051
[TBL] [Abstract][Full Text] [Related]
12. VKOR paralog VKORC1L1 supports vitamin K-dependent protein carboxylation in vivo.
Lacombe J; Rishavy MA; Berkner KL; Ferron M
JCI Insight; 2018 Jan; 3(1):. PubMed ID: 29321368
[TBL] [Abstract][Full Text] [Related]
13. VKCFD2 - from clinical phenotype to molecular mechanism.
Czogalla KJ; Watzka M; Oldenburg J
Hamostaseologie; 2016 Nov; 36(Suppl. 2):S13-S20. PubMed ID: 27824210
[TBL] [Abstract][Full Text] [Related]
14. Warfarin alters vitamin K metabolism: a surprising mechanism of VKORC1 uncoupling necessitates an additional reductase.
Rishavy MA; Hallgren KW; Wilson L; Singh S; Runge KW; Berkner KL
Blood; 2018 Jun; 131(25):2826-2835. PubMed ID: 29592891
[TBL] [Abstract][Full Text] [Related]
15. Vitamin K-induced modification of coagulation phenotype in VKORC1 homozygous deficiency.
Marchetti G; Caruso P; Lunghi B; Pinotti M; Lapecorella M; Napolitano M; Canella A; Mariani G; Bernardi F
J Thromb Haemost; 2008 May; 6(5):797-803. PubMed ID: 18315553
[TBL] [Abstract][Full Text] [Related]
16. A new cell culture-based assay quantifies vitamin K 2,3-epoxide reductase complex subunit 1 function and reveals warfarin resistance phenotypes not shown by the dithiothreitol-driven VKOR assay.
Fregin A; Czogalla KJ; Gansler J; Rost S; Taverna M; Watzka M; Bevans CG; Müller CR; Oldenburg J
J Thromb Haemost; 2013 May; 11(5):872-80. PubMed ID: 23452238
[TBL] [Abstract][Full Text] [Related]
17. Conserved loop cysteines of vitamin K epoxide reductase complex subunit 1-like 1 (VKORC1L1) are involved in its active site regeneration.
Tie JK; Jin DY; Stafford DW
J Biol Chem; 2014 Mar; 289(13):9396-407. PubMed ID: 24532791
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of protein disulfide isomerase enhances vitamin K epoxide reductase activity.
Chetot T; Benoit E; Lambert V; Lattard V
Biochem Cell Biol; 2022 Apr; 100(2):152-161. PubMed ID: 35007172
[TBL] [Abstract][Full Text] [Related]
19. Enhanced functional recombinant factor IX production by human embryonic kidney cells engineered to overexpress VKORC1.
Pakdaman SF; Vatandoost J; Bos MHA
Biotechnol Prog; 2020 Mar; 36(2):e2938. PubMed ID: 31677255
[TBL] [Abstract][Full Text] [Related]
20. VKORC1 and VKORC1L1 have distinctly different oral anticoagulant dose-response characteristics and binding sites.
Czogalla KJ; Liphardt K; Höning K; Hornung V; Biswas A; Watzka M; Oldenburg J
Blood Adv; 2018 Mar; 2(6):691-702. PubMed ID: 29581108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
